SHW
56
-2
LH
69
3
SWK
70
2
GPC
74
-2
MCHP
65
-3
AFL
42
-2
EQR
28
3
NTRS
54
2
T
51
-2
NWSA
35
15
FLR
23
-2
EIX
74
2
EQT
65
5
FLS
50
2
QRVO
67
2
STZ
33
-9
NWL
52
4
AVGO
31
-9
ICE
44
3
KHC
18
3
SHW
56
-2
LH
69
3
SWK
70
2
GPC
74
-2
MCHP
65
-3
AFL
42
-2
EQR
28
3
NTRS
54
2
T
51
-2
NWSA
35
15
FLR
23
-2
EIX
74
2
EQT
65
5
FLS
50
2
QRVO
67
2
STZ
33
-9
NWL
52
4
AVGO
31
-9
ICE
44
3
KHC
18
3
Financhill
Back

Takeda Pharmaceutical Co., Ltd. 10K Form

Buy
83

TAK
Takeda Pharmaceutical Co., Ltd.

Last Price:
$18.49
Seasonality Move:
-3.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TAK News And Ratings

See the #1 stock for the next 7 days that we like better than TAK

TAK Financial Statistics

Sales & Book Value

Annual Sales: $30.1B
Cash Flow: $822.4M
Price / Cash Flow: 13.47
Annual Sales: $15.43
Price / Book: 1.2

Profitability

EPS (TTM): 0.24080
Net Income (TTM): $776.9M
Gross Margin: $16.1B
Return on Equity: 1.63%
Return on Assets: 0.8%

Takeda Pharmaceutical Co., Ltd. Earnings Forecast

Key Takeda Pharmaceutical Co., Ltd. Financial Ratios

  • The Gross Profit Margin over the past 35 years for TAK is 53.59%.
  • The Selling, General & Administrative Expenses for TAK have been equal to 24.11% of Gross Profit Margin.
  • The Research & Development expenses have been 15.94% of Revenue.
  • The Interest Expense is 172.90% of Operating Income.
  • The Net Earning history of TAK is 2.36% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 23 years.

Takeda Pharmaceutical Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TAK
CUSIP: 874060
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 1.19
Quick Ratio: 0.53

Price-to-Earnings

Trailing P/E Ratio: 83.72
Forward P/E Ratio: 0

TAK Technical Analysis vs Fundamental Analysis

Buy
83
Takeda Pharmaceutical Co., Ltd. (TAK) is a Buy

Is Takeda Pharmaceutical Co., Ltd. a Buy or a Sell?